Boston Scientific gets 3 FDA approvals (Boston Globe)
Medical device maker Boston Scientific Corp. said Monday the U.S. Food and Drug Administration granted approval for three of its heart-related products: Confient, Livian and upgraded Latitude.

Breast Cancer Action Disagrees With FDA's Avastin Ruling (Medical News Today)
Breast Cancer Action (BCA) strongly disagrees with the Food and Drug Administration's decision giving accelerated approval to biotech company Genentech's application to market its drug Avastin as a treatment for metastatic breast cancer at this time. "The FDA has lowered the bar on the approval of breast cancer therapies.